Pivotport’s CEO, Rajiv Mistry has completed “AI in Healthcare” certification at MIT XPro. The course involved seven modules, as well as assignments and discussions for each.

Pivotport’s CEO, Rajiv Mistry has completed “AI in Healthcare” certification at MIT XPro. The course involved seven modules, as well as assignments and discussions for each.

University of Chicago’s Polsky Institute for Innovation has chosen three startups as the first cohort for its Transform Data Science and AI Accelerator. Through a parallel selection process, mentors for these startups are also appointed to the role of Executive in Residence. Pivotport’s CEO, Rajiv Mistry has been selected as a mentor for Drip, a startup bringing wearable sensor based athletic clothing for sweat based hydration detection and optimization.
The selected startups in cohort 1 will receive mentoring for a ten-week period between April to June 2023 in multiple aspects of startup considerations for their readiness to launch successfully.
Here are details about Transform Cohort 2 information session on April 26th, 2023 at noon CT and application.
Excerpts from “Quantum Computing in Healthcare & Life Sciences” Webinar by Nardo Manaloto
What is Quantum Engineering, Computing, Detection, Sensing & Noise?
Explanation of Quantum Engineering, Computing, Detection, Sensing, Noise by Rajiv Mistry @ 1:28:15
Pivotport Elevator Pitch
Pivotport Elevator Pitch by Rajiv Mistry @1:32:00
Our startup is developing a cutting-edge technology for early detection and identification of cardiac anomalies using quantum computing. By harnessing the power of quantum computing, our technology is able to analyze vast amounts of data from electrocardiograms and generate cardiac spectrograms, to provide highly accurate and actionable results to support quicker cardiac anomaly diagnosis.
This technology has the potential to revolutionize the way cardiac anomalies are detected and treated, leading to better outcomes for patients and significant cost savings for the healthcare system. With your investment, we will be able to bring this innovative technology to market and make a real impact on people’s lives.
Additionally, we are also targeting to expand our technology to other medical applications such as brain anomalies detection.
We are seeking funding to support the development and commercialization of our technology. With your support, we can bring Quantum Cardiac Anomaly Detection to the market and change the way cardiac anomalies are detected and treated.
Thank you for considering our proposal. We would be happy to discuss this opportunity further with you and answer any questions you may have. Please connect by booking a Teams call via the Contact page.
You must be logged in to post a comment.